Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Healthtrust
Express Scripts
Deloitte
Chinese Patent Office
Covington
Fuji
Farmers Insurance
Merck
Johnson and Johnson

Generated: January 19, 2018

DrugPatentWatch Database Preview

Finasteride - Generic Drug Details

« Back to Dashboard

What are the generic sources for finasteride and what is the scope of finasteride patent protection?

Finasteride
is the generic ingredient in three branded drugs marketed by Accord Hlthcare, Actavis Totowa, Actavis Totowa Teva, Alkem Labs Ltd, Aurobindo Pharma, Aurobindo Pharma Ltd, Cipla Ltd, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Gedeon Richter Usa, Hetero Labs Ltd Iii, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sun Pharma Global, Teva, Zydus Pharms Usa Inc, and Merck, and is included in twenty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Finasteride has six patent family members in five countries.

There are fourteen drug master file entries for finasteride. Forty-one suppliers are listed for this compound.
Pharmacology for finasteride
Medical Subject Heading (MeSH) Categories for finasteride

US Patents and Regulatory Information for finasteride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc FINASTERIDE finasteride TABLET;ORAL 078900-001 Dec 28, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hetero Labs Ltd Iii FINASTERIDE finasteride TABLET;ORAL 090060-001 Jul 1, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Totowa Teva FINASTERIDE finasteride TABLET;ORAL 077914-001 Mar 28, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare FINASTERIDE finasteride TABLET;ORAL 090121-001 Feb 23, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alkem Labs Ltd FINASTERIDE finasteride TABLET;ORAL 204304-001 Jan 5, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hetero Labs Ltd Iii FINASTERIDE finasteride TABLET;ORAL 090061-001 Jun 7, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alkem Labs Ltd FINASTERIDE finasteride TABLET;ORAL 207750-001 Jan 6, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd FINASTERIDE finasteride TABLET;ORAL 203687-001 Nov 5, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva FINASTERIDE finasteride TABLET;ORAL 076511-001 Dec 15, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gedeon Richter Usa FINASTERIDE finasteride TABLET;ORAL 077251-001 Dec 22, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for finasteride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Fish and Richardson
Daiichi Sankyo
Cerilliant
Chubb
Dow
Deloitte
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot